Relief Therapeutics Holding SA (RLFTF)
1.25
+0.06
(+5.04%)
USD |
OTCM |
Jun 14, 16:00
Relief Therapeutics Price: 1.25 for June 14, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Jun 14, 2024 | 1.315 | 1.43 | 1.245 | 1.25 | 761.00 |
| Jun 13, 2024 | 1.315 | 1.315 | 1.19 | 1.19 | 2591.00 |
| Jun 12, 2024 | 1.42 | 1.42 | 1.25 | 1.40 | 7895.00 |
| Jun 11, 2024 | 1.47 | 1.47 | 1.36 | 1.47 | 509.00 |
| Jun 10, 2024 | 1.47 | 1.47 | 1.47 | 1.47 | 257.00 |
| Jun 07, 2024 | 1.24 | 1.33 | 1.24 | 1.305 | 11813.00 |
| Jun 06, 2024 | 1.354 | 1.49 | 1.342 | 1.381 | 1738.00 |
| Jun 05, 2024 | 1.338 | 1.43 | 1.25 | 1.25 | 1504.00 |
| Jun 04, 2024 | 1.375 | 1.46 | 1.375 | 1.45 | 1183.00 |
| Jun 03, 2024 | 1.55 | 1.55 | 1.406 | 1.406 | 396.00 |
| May 31, 2024 | 1.52 | 1.52 | 1.52 | 1.52 | 332.00 |
| May 30, 2024 | 1.52 | 1.54 | 1.424 | 1.54 | 1451.00 |
| May 29, 2024 | 1.30 | 1.48 | 1.30 | 1.48 | 3049.00 |
| May 28, 2024 | 1.49 | 1.49 | 1.49 | 1.49 | 400.00 |
| May 24, 2024 | 1.49 | 1.49 | 1.46 | 1.46 | 666.00 |
| May 23, 2024 | 1.381 | 1.48 | 1.25 | 1.47 | 814.00 |
| May 22, 2024 | 1.45 | 1.48 | 1.37 | 1.48 | 854.00 |
| May 21, 2024 | 1.48 | 1.48 | 1.309 | 1.48 | 665.00 |
| May 20, 2024 | 1.375 | 1.44 | 1.375 | 1.44 | 783.00 |
| May 17, 2024 | 1.44 | 1.44 | 1.44 | 1.44 | 366.00 |
| May 16, 2024 | 1.42 | 1.44 | 1.33 | 1.375 | 2462.00 |
| May 15, 2024 | 1.378 | 1.42 | 1.378 | 1.42 | 1413.00 |
| May 14, 2024 | 1.52 | 1.52 | 1.40 | 1.42 | 7744.00 |
| May 13, 2024 | 1.36 | 1.36 | 1.32 | 1.32 | 963.00 |
| May 10, 2024 | 1.35 | 1.40 | 1.30 | 1.328 | 1834.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.19
Minimum
Jun 13 2024
320.40
Maximum
Aug 06 2020
48.73
Average
14.24
Median
Jun 09 2022
Price Benchmarks
| AC Immune SA | 4.26 |
| CRISPR Therapeutics AG | 63.56 |
| Addex Therapeutics Ltd | 8.61 |
| NLS Pharmaceutics Ltd | 0.1139 |
| Molecular Partners AG | 6.77 |
Price Related Metrics
| PS Ratio | 2.173 |
| PEG Ratio | -0.0012 |
| Price to Book Value | 0.2521 |
| Earnings Yield | -747.7% |
| Market Cap | 15.68M |
| PEGY Ratio | -0.0012 |